Rapid POC GAS Diagnostics in the Paediatric ED

Clinical Trial Summary

Randomized trial evaluating effectiveness of rapid point-of-care molecular GAS diagnostics as compared to standard culture-based techniques for the management of children aged 3-18 years of age presenting with sore throat to McMaster Children's Hospital Emergency Department.

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01558804` - GRoup A StrePtococcus
Completed	`NCT01806103` - Antimicrobial Stewardship for Primary Care Pediatricians	N/A
Recruiting	`NCT05521568` - Diagnostic Accuracy of Rapid Molecular Tests for Group A Streptococcal Pharyngitis Using Saliva Samples

See also

Status

Clinical Trial

Phase

Recruiting

NCT01558804 - GRoup A StrePtococcus

Completed

NCT01806103 - Antimicrobial Stewardship for Primary Care Pediatricians

N/A

Recruiting

NCT05521568 - Diagnostic Accuracy of Rapid Molecular Tests for Group A Streptococcal Pharyngitis Using Saliva Samples

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04247243
Study type	Interventional
Source	Hamilton Health Sciences Corporation
Contact	Jeffrey Pernica, MD
Phone	9055212100
Email	pernica@mcmaster.ca
Status	Recruiting
Phase	N/A
Start date	January 4, 2021
Completion date	May 1, 2024

Rapid POC GAS Diagnostics in the Paediatric ED

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms